Scancell (LON:SCLP) Stock Price Up 5.4%

Scancell Holdings plc (LON:SCLP)’s stock price was up 5.4% on Tuesday . The stock traded as high as GBX 19.75 ($0.25) and last traded at GBX 19.50 ($0.25). Approximately 3,216,075 shares changed hands during mid-day trading, an increase of 411% from the average daily volume of 629,645 shares. The stock had previously closed at GBX 18.50 ($0.24).

Scancell Stock Performance

The stock has a market cap of £181.27 million, a P/E ratio of -1,950.00 and a beta of 0.38. The stock has a fifty day simple moving average of GBX 12.39 and a 200-day simple moving average of GBX 11.06. The company has a quick ratio of 13.01, a current ratio of 8.63 and a debt-to-equity ratio of 61.41.

Scancell Company Profile

Scancell Holdings plc, a clinical stage biopharmaceutical company, engages in the discovery and development of novel immunotherapies and vaccines for the treatment of cancer and infectious disease. Its product candidates include SCIB1, an ImmunoBody cancer vaccine that is in Phase II for the treatment of metastatic melanoma; and SCIB2/iSCIB2 vaccine, which is under evaluation for the treatment of patients with solid tumors, including non-small cell lung cancer.